Dynamic evolution of ponatinib-resistant mutations in BCR-ABL1-positive leukaemias revealed by next-generation sequencing

被引：5
|
作者：
Chen, Jiaqi [1 ,2 ]
Wang, Fang [1 ]
Fang, Jiancheng [1 ]
Nie, Daijing [1 ]
Zhang, Yang [1 ]
Chen, Xue [1 ]
Li, Yu [3 ]
Tan, Yincheng [1 ]
Ma, Xiaoli [1 ]
Guo, Yongxin [1 ]
Cao, Panxiang [1 ]
Liu, Ming [1 ]
Liu, Hongxing [1 ,2 ,3 ]
机构：
[1] Hebei Yanda Lu Daopei Hosp, Div Pathol & Lab Med, Langfang, Peoples R China
[2] Beijing Lu Daopei Inst Hematol, Beijing, Peoples R China
[3] Beijing Lu Daopei Hosp, Div Pathol & Lab Med, Beijing, Peoples R China
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 191卷 / 05期
关键词：
BCR-ABL1; tyrosine kinase inhibitors; next-generation sequencing; drug-resistant mutation; compound mutations; COMPOUND MUTATIONS; BCR-ABL1; ASCIMINIB;
D O I：
10.1111/bjh.17068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E113 / E116
页数：4
相关论文
共 50 条
  • [1] Activity of omacetaxine mepesuccinate against ponatinib-resistant BCR-ABL-positive cells
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Tanaka, Yuko
    Katagiri, Seiichiro
    Kitahara, Toshihiko
    Ohyashiki, Kazuma
    BLOOD, 2013, 122 (17) : 3086 - 3088
  • [2] Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1-Positive Leukemia
    Katagiri, Seiichiro
    Tauchi, Tetsuzo
    Okabe, Seiichi
    Minami, Yosuke
    Kimura, Shinya
    Maekawa, Taira
    Naoe, Tomoki
    Ohyashiki, Kazuma
    CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1422 - 1432
  • [3] Dynamic Evolution of Ponatinib Resistant BCR-ABL1 T315 and Compound Mutations
    Chen, Jiaqi
    Liu, Hongxing
    Wang, Fang
    Zhang, Yang
    Chen, Xue
    Nie, Daijing
    Li, Yu
    Tan, Yincheng
    Xu, Yuanli
    Ma, Xiaoli
    BLOOD, 2019, 134
  • [4] Ultradeep Error Corrected Next-generation Sequencing (NGS) of ABL1 Kinase Domain Mutations in BCR-ABL1 Positive Malignancies
    Patkar, N.
    Mehta, A.
    Joshi, S.
    Kodgule, R.
    Chaudhary, S.
    Raval, G.
    Mishra, B.
    Battapadi, T.
    Tembhare, P.
    Subramanian, P.
    Gujra, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 923 - 923
  • [5] BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing
    Mroczkowska-Bekarciak, Aleksandra
    Wrobel, Tomasz
    FRONTIERS IN GENETICS, 2023, 14
  • [6] Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations
    Klairmont, M. M.
    Cheng, J.
    Schwartzberg, L.
    Ho, H. H.
    Gradowski, J. F.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (03) : E41 - E42
  • [7] Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients
    Soverini, Simona
    De Benedittis, Caterina
    Polakova, Katerina Machova
    Linhartova, Jana
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Papayannidis, Cristina
    Mancini, Manuela
    Klamova, Hana
    Salvucci, Marzia
    Crugnola, Monica
    Iurlo, Alessandra
    Albano, Francesco
    Russo, Domenico
    Rosti, Gianantonio
    Cavo, Michele
    Baccarani, Michele
    Martinelli, Giovanni
    ONCOTARGET, 2016, 7 (16) : 21982 - 21990
  • [8] A Novel Next-Generation Sequencing Assay for the Identification of BCR::ABL1 Transcript Type and Accurate and Sensitive Detection of TKI-Resistant Mutations
    Yan, Zhenyu
    Shi, Lin
    Li, Wei
    Liu, Weihua
    Galderisi, Chad
    Spittle, Cynthia
    Li, Jin
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2024, 9 (06): : 886 - 900
  • [9] Detection and Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing
    Vannuffel, Pascal
    Cauwelier, Barbara
    De Rop, Celine
    Nollet, Friedel
    BLOOD, 2015, 126 (23)
  • [10] Next-generation deep-sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPN
    S Jeromin
    A Kohlmann
    M Meggendorfer
    S Schindela
    K Perglerová
    N Nadarajah
    W Kern
    C Haferlach
    T Haferlach
    S Schnittger
    Leukemia, 2016, 30 : 973 - 976
12345